Diagnostic data of serum levels of TAC, Ox-LDL, and CA15-3 using ROC curve
Variable
AUC
SE
95% CI
Sensitivity
Specificity
Cutoff value
TAC
0.975
0.0247
0.870 to 0.997
100
86.4
18.9
Ox-LDL
0.986
0.0225
0.887 to 0.999
97.9
100
998
CA15-3
0.913
0.0518
0.736 to 0.947
69.7
96.4
22.1
SE: standard error; TAC: total antioxidant capacity; Ox-LDL: oxidized low-density lipoprotein; CA: cancer antigen; ROC: receiver operating characteristic
Declarations
Acknowledgments
The authors express their gratitude to the staff at the oncology unit of King Abdallah Medical City in Makkah for their assistance in conducting the research by examining the patients and collecting data.
Author contributions
ATB: Conceptualization, Investigation, Data curation, Writing—original draft, Writing—review & editing. MMNE: Conceptualization, Investigation, Data curation, Writing—original draft, Writing—review & editing. Both authors read and approved the final manuscript.
Conflicts of interest
All authors declare no conflicts of interest.
Ethical approval
This study complied with the ethical standards specified in the 1975 Declaration of Helsinki, and clearance was obtained from the medical ethics committee of the College of Medicine at Umm Al-Qura University in Makkah, Kingdom of Saudi Arabia (Approval Number: HAPO-02-K012-2022-09-1183).
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Consent to publication
Not applicable.
Availability of data and materials
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern.Br J Radiol. 2022;95:20211033. [DOI] [PubMed] [PMC]
Nour Eldin EE, Almarzouki A, Assiri AM, Elsheikh OM, Mohamed BE, Babakr AT. Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men.Diabetol Metab Syndr. 2014;6:94. [DOI] [PubMed] [PMC]
Demirci-Çekiç S, Özkan G, Avan AN, Uzunboy S, Çapanoğlu E, Apak R. Biomarkers of Oxidative Stress and Antioxidant Defense.J Pharm Biomed Anal. 2022;209:114477. [DOI] [PubMed]
Babakr AT, Althubiti M. Impact of Antioxidant-Rich Diet on Decreasing Oxidized Low-Density Lipoproteins, 8-Hydroxy-2’-Deoxyguanosine and Hba1c in Saudi Men.Biomed Pharmacol J. 2023;16. [DOI]
Kangari P, Zarnoosheh Farahany T, Golchin A, Ebadollahzadeh S, Salmaninejad A, Mahboob SA, et al. Enzymatic Antioxidant and Lipid Peroxidation Evaluation in the Newly Diagnosed Breast Cancer Patients in Iran.Asian Pac J Cancer Prev. 2018;19:3511–5. [DOI] [PubMed] [PMC]
Didžiapetrienė J, Kazbarienė B, Tikuišis R, Dulskas A, Dabkevičienė D, Lukosevičienė V, et al. Oxidant/Antioxidant Status of Breast Cancer Patients in Pre- and Post-Operative Periods.Medicina (Kaunas). 2020;56:70. [DOI] [PubMed] [PMC]
Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer.Clin Biochem. 2007;40:1129–34. [DOI] [PubMed]
Khalaf MY, Mohammed AA, Mosa AA, Arif SH, Mustafa JA. The correlation of antioxidant levels of breast cancer: A case controlled study.Medicine (Baltimore). 2021;100:e26878. [DOI] [PubMed] [PMC]
Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy.Nat Rev Drug Discov. 2021;20:689–709. [DOI] [PubMed] [PMC]
Fatani SH, Babakr AT, NourEldin EM, Almarzouki AA. Lipid peroxidation is associated with poor control of type-2 diabetes mellitus.Diabetes Metab Syndr. 2016;10:S64–7. [DOI] [PubMed]
Babakr AT. Scavenger Receptors: Different Classes and their Role in the Uptake of Oxidized Low-Density Lipoproteins.Biomed Pharmacol J. 2024;17:699–712.
Cserni G, Chmielik E, Cserni B, Tot T. The new TNM-based staging of breast cancer.Virchows Arch. 2018;472:697–703. [DOI] [PubMed]
Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer.Breast Cancer Res Treat. 2000;59:163–70. [DOI] [PubMed]
Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU. Oxidative stress and its role in cancer.J Cancer Res Ther. 2021;17:22–8. [DOI] [PubMed]
Delrieu L, Touillaud M, Pérol O, Morelle M, Martin A, Friedenreich CM, et al. Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer.Oxid Med Cell Longev. 2021;2021:6694594. [DOI] [PubMed] [PMC]
de Oliveira ST, Bessani MP, Scandolara TB, Silva JC, Kawassaki ACB, Fagotti PAF, et al. Systemic lipid peroxidation profile from patients with breast cancer changes according to the lymph nodal metastasis status.Oncoscience. 2022;9:1–10. [DOI] [PubMed] [PMC]
Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy.ISRN Oncol. 2012;2012:137289. [DOI] [PubMed] [PMC]
Liu X, Zhao J, Zheng R. DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients.Mutat Res. 2003;539:1–8. [PubMed]
Zhang F, Deng Y, Drabier R. Multiple biomarker panels for early detection of breast cancer in peripheral blood.Biomed Res Int. 2013;2013:781618. [DOI] [PubMed] [PMC]
Hasan D. Diagnostic impact of CEA and CA 15-3 on chemotherapy monitoring of breast cancer patients.J Circ Biomark. 2022;11:57–63. [DOI] [PubMed] [PMC]
Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value?Clin Chem. 2006;52:345–51. [DOI] [PubMed]
Postovit L, Widmann C, Huang P, Gibson SB. Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy.Oxid Med Cell Longev. 2018;2018:6135739. [DOI] [PubMed] [PMC]
Mobley JA, Brueggemeier RW. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer.Carcinogenesis. 2004;25:3–9. [DOI] [PubMed]
Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents--DNA adducts and mutations.J Natl Cancer Inst Monogr. 2000:75–93. [DOI] [PubMed]
Tahmasebpour N, Hosseinpour Feizi MA, Ziamajidi N, Pouladi N, Montazeri V, Farhadian M, et al. Association of Omentin-1 with Oxidative Stress and Clinical Significances in Patients with Breast Cancer.Adv Pharm Bull. 2020;10:106–13. [DOI] [PubMed] [PMC]
Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P. 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.Br J Cancer. 2010;102:1018–23. [DOI] [PubMed] [PMC]
Althubiti M, Elzubier M, Alotaibi GS, Althubaiti MA, Alsadi HH, Alhazmi ZA, et al. Beta 2 microglobulin correlates with oxidative stress in elderly.Exp Gerontol. 2021;150:111359. [DOI] [PubMed]
Senoner T, Dichtl W. Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?Nutrients. 2019;11:2090. [DOI] [PubMed] [PMC]
